O PROTIVOVOSPALITEL'NYKh SVOYSTVAKh MAKROLIDOV


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

About the authors

V FISENKO

N ChIChKOVA

References

  1. Цветкова О. Макролиды в терапии внебольничной пневмонии и обострений ХОБЛ. // Врач. - 2004. - № 6. - С. 50-53.
  2. Basygyt I., Yildiz F., Ozkara S.K. et al. The effect of claritromycin on inflammatory markers in chronic obstructive pulmonary disease. Preliminary data. // The Annals of pharmacotherapy. - 2004. - V. 38. - P. 17-23.
  3. Cuffini A.M., Tullio V., Mandras N. et al. Claritromycin mediated the expression of polymorphonuclear granulocyte response against Streptococcus pneumoniae strains with different patterns of subceptibility and resistance to penicillinum and claritromycin. // Int. J. Tissue React. - 2002. - V. XXIV, № 1 - Р. 37-44.
  4. Dorca J., Padrones S., Manresa F. Macrolides and lower respiratory infections. // Europ. Respir. Monogr. - 2004. - V. 9. - № 28. - Р. 78-93.
  5. Ferrara G., Losi M., Franco F et al. // Macrolides in the treatment of asthma and cystic fibrosis. // Respiratory Med. - 2005. - V. 99. - P. 1-10.
  6. Gotfried M.H. Macrolides for the treatment of chronic sinusitis,asthma and COPD. // Chest - 2004. - V.125. - Suppl. - P. 52S-61S.
  7. Hatipoglu U., Rubinstein I. Low-dose, long-term macrolide therapy in asthma: An overview. // Clin. Molecul. Allergy. - 2004. - V. 2. - № 4. - Р. 12-17.
  8. Kanai K., Asana K., Hisamitsu T. // Europ. Respir. J. - 2004. - V. 23. - P. 671-678.
  9. Kostadima E., Tsiodras S., Alexopoulos E.I. et al. // Europ. Respir. J. - 2004. - V. 23 - P. 714-717.
  10. Kraft M., Cassel G.H., Pak J. et al. // Chest. - 2002. - V. 121. - P. 1782-1788.
  11. Labro M.T. Antibiotics as anti-inflammatory drugs. // Curr. Op. Investig. Drugs. - 2002. - V. 3. - P. 61-68.
  12. Labro M.T. Interaction of antibacterial agents with host respiratory defences. // Europ. Respir. Monogr. - 2004 - V. 9. - № 28. - Р. 45-63.
  13. Rubin B., Henke M.O. Immunomodulatory activity and effectiveness of macrolides in chronic airway disease. // Chest. - 2004. - V. 125. Suppl. - P. 70S-78S.
  14. Tamaoki J. The effects of macrolides on inflammatory cells. // Chest. - 2004. - V. 125. - Suppl. - P. 41S-51S.
  15. Ives T.J. // Research communication in molecular pathology and pharmacology. - 2001. - V. 110 (3-4). - P. 83-208.
  16. Morikawa K. et. al. // International Journal of antimicrobial agents. -2002, January. - V. 191. - P. 53-59.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies